AMZN
Amazon.com, Inc.
AMZN has the edge over IP overall, supported by stronger fundamentals and stronger valuation.
IP
International Paper Company
IP's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
IP Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Stable | |
| Weak |
IP's cash flow is currently stable, but its revenue, profitability and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
IP PE Valuation
IP has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
IP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for IP, with profitability improving. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over IP on earnings quality, reporting a profit while its opponent remains loss making.
IP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.18 | — |
| Q3 2026 | -$6.56 | -$3.95 |
| Q2 2026 | -$6.52 | -$6.42 |
| Q1 2026 | -$6.36 | -644% |
| Q4 2025 | -$6.71 | -527% |
| Q3 2025 | -$2.61 | -323% |
| Q2 2025 | -$0.10 | -108% |
| Q1 2025 | $1.17 | +139% |
| Q4 2024 | $1.57 | +91% |
IP lost $6.56 per share over the past year, a bigger loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over IP on profitability, with a higher operating margin.
IP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.2B | -0.4% |
| Q2 2026 | $6B | -11% |
| Q1 2026 | $6B | +1.2% |
| Q4 2025 | $6B | +31% |
| Q3 2025 | $6.2B | +33% |
| Q2 2025 | $6.8B | +43% |
| Q1 2025 | $5.9B | +28% |
| Q4 2024 | $4.6B | -0.5% |
IP's revenue has held roughly level: $6.2B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -19% | -8.4 points |
| Q2 2026 | -0.4% | -2.1 points |
| Q1 2026 | 1.6% | +3.9 points |
| Q4 2025 | -44% | -39 points |
| Q3 2025 | -11% | -16 points |
| Q2 2025 | 1.7% | -5.1 points |
| Q1 2025 | -2.3% | -6 points |
| Q4 2024 | -4.9% | +2.2 points |
IP's operating margin was −19% last quarter, down 8.4 points from the same quarter a year ago, near the bottom of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
IP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$267M | -278% |
| Q2 2026 | -$7M | -113% |
| Q1 2026 | $94M | +$712M |
| Q4 2025 | $255M | +86% |
| Q3 2025 | $150M | -51% |
| Q2 2025 | $54M | -68% |
| Q1 2025 | -$618M | -529% |
| Q4 2024 | $137M | -27% |
IP has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
IP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +0.3% | +1.6M shares |
| 3 years | +53% | +183M shares |
| 5 years | +26% | +111M shares |
| Available history | +26% | +108M shares |
IP has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1M |
| Q1 2026 | $30M |
| Q4 2025 | $1M |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | $62M |
| Q4 2024 | $1M |
IP spent $32M buying back its own shares over the past year, down 51% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
IP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 5.2x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 4.7x | High |
| Q4 2024 | 2.4x | Moderate |
| Q3 2024 | 2.3x | Moderate |
| Q2 2024 | 2.3x | Moderate |
| Q1 2024 | 2.3x | Moderate |
| Q4 2023 | 2.1x | Moderate |
IP's net debt is about 5.2 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
IP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.4 | Neutral |
| Stochastic | 31.0 | Neutral |
IP's weekly RSI is 44 (neutral) and its Stochastic is 31 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
IP PE vs Consumer Cyclical Sector
| Metric | IP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
IP has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over IP on trend strength, trading above more of its moving averages.
IP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.9 | 0.1% above |
| 20 week MA | $36.9 | 8% below |
| 50 week MA | $37.6 | 9.8% below |
| 100 week MA | $43.3 | 22% below |
| 200 week MA | $41.3 | 18% below |
IP has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 18% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over IP on returns for 2026, with the stronger performance.
IP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.5 | $47.1 | +8.4% |
| 2021 | $47.1 | $45.8 | -2.7% |
| 2022 | $45.8 | $34.7 | -24% |
| 2023 | $34.7 | $36.2 | +4.1% |
| 2024 | $36.2 | $54.5 | +51% |
| 2025 | $54.5 | $39.9 | -27% |
| 2026 YTD | $39.9 | $33.9 | -15% |
IP has finished lower in three of the last six years. It's down 15% so far in 2026.